Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Preparation, carbonic anhydrase enzyme inhibition and antioxidant activity of novel 7-amino-3,4-dihydroquinolin-2(1H)-one derivatives incorporating mono or dipeptide moiety.

Tytuł:
Preparation, carbonic anhydrase enzyme inhibition and antioxidant activity of novel 7-amino-3,4-dihydroquinolin-2(1H)-one derivatives incorporating mono or dipeptide moiety.
Autorzy:
Küçükbay H; Department of Chemistry, Faculty of Arts and Sciences, İnönü University, Malatya, Turkey.
Gönül Z; Department of Chemistry, Faculty of Arts and Sciences, İnönü University, Malatya, Turkey.
Küçükbay FZ; Department of Basic Pharmaceutical Sciences, Faculty of Pharmacy, İnönü University, Malatya, Turkey.
Angeli A; Dipartimento Neurofarba, Sezione Di Scienze Farmaceutiche E Nutraceutiche e Laboratorio Di Chimica Bioinorganica, Università Degli Studi Di Firenze, Florence, Italy.
Bartolucci G; Dipartimento Neurofarba, Sezione Di Scienze Farmaceutiche E Nutraceutiche e Laboratorio Di Chimica Bioinorganica, Università Degli Studi Di Firenze, Florence, Italy.
Supuran CT; Dipartimento Neurofarba, Sezione Di Scienze Farmaceutiche E Nutraceutiche e Laboratorio Di Chimica Bioinorganica, Università Degli Studi Di Firenze, Florence, Italy.
Źródło:
Journal of enzyme inhibition and medicinal chemistry [J Enzyme Inhib Med Chem] 2020 Dec; Vol. 35 (1), pp. 1021-1026.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: Basingstoke, UK : Taylor & Francis, c2002-
MeSH Terms:
Antioxidants/*pharmacology
Biphenyl Compounds/*antagonists & inhibitors
Carbonic Anhydrase Inhibitors/*pharmacology
Carbonic Anhydrases/*metabolism
Dipeptides/*pharmacology
Picrates/*antagonists & inhibitors
Quinolones/*pharmacology
Antioxidants/chemical synthesis ; Antioxidants/chemistry ; Carbonic Anhydrase Inhibitors/chemical synthesis ; Carbonic Anhydrase Inhibitors/chemistry ; Dipeptides/chemistry ; Dose-Response Relationship, Drug ; Humans ; Isoenzymes/antagonists & inhibitors ; Isoenzymes/metabolism ; Molecular Structure ; Quinolones/chemical synthesis ; Quinolones/chemistry ; Structure-Activity Relationship
References:
Bioorg Med Chem Lett. 2008 Mar 1;18(5):1583-7. (PMID: 18242985)
Eur J Med Chem. 2017 Dec 1;141:335-345. (PMID: 29031077)
Bioorg Chem. 2019 Mar;83:414-423. (PMID: 30419497)
Biochem J. 2016 Jul 15;473(14):2023-32. (PMID: 27407171)
Expert Opin Drug Metab Toxicol. 2016;12(4):423-31. (PMID: 26878088)
Bioorg Med Chem. 2007 Jul 1;15(13):4336-50. (PMID: 17475500)
Expert Opin Drug Discov. 2019 Nov;14(11):1175-1197. (PMID: 31436118)
J Med Chem. 2013 Jan 10;56(1):293-300. (PMID: 23241068)
J Enzyme Inhib Med Chem. 2015;30(5):773-7. (PMID: 25672528)
Bioorg Med Chem. 2008 Aug 1;16(15):7424-8. (PMID: 18579385)
Med Res Rev. 2018 Sep;38(6):1799-1836. (PMID: 29635752)
J Enzyme Inhib Med Chem. 2018 Dec;33(1):1299-1308. (PMID: 30249139)
Expert Rev Neurother. 2015;15(8):851-6. (PMID: 26154918)
Metabolites. 2017 Nov 11;7(4):. (PMID: 29137134)
J Enzyme Inhib Med Chem. 2018 Dec;33(1):1453-1459. (PMID: 30221552)
Expert Opin Ther Pat. 2018 Oct;28(10):729-740. (PMID: 30074415)
Bioorg Med Chem Lett. 2001 Jul 9;11(13):1787-91. (PMID: 11425561)
J Enzyme Inhib Med Chem. 2018 Dec;33(1):485-495. (PMID: 29390912)
J Enzyme Inhib Med Chem. 2020 Dec;35(1):489-497. (PMID: 31914827)
Expert Opin Ther Pat. 2018 Jun;28(6):493-504. (PMID: 29727210)
J Inorg Biochem. 2012 Jun;111:117-29. (PMID: 22192857)
Angew Chem Int Ed Engl. 2007;46(40):7697-9. (PMID: 17705204)
Expert Opin Ther Pat. 2018 Oct;28(10):709-712. (PMID: 30217119)
Bioorg Chem. 2018 Dec;81:311-318. (PMID: 30176570)
Expert Opin Ther Pat. 2019 Oct;29(10):781-792. (PMID: 31596641)
J Enzyme Inhib Med Chem. 2013 Apr;28(2):392-6. (PMID: 22299588)
J Enzyme Inhib Med Chem. 2016 Dec;31(6):1198-202. (PMID: 26586254)
Bioorg Med Chem. 2008 Oct 15;16(20):9101-5. (PMID: 18819808)
Nat Rev Drug Discov. 2008 Feb;7(2):168-81. (PMID: 18167490)
J Enzyme Inhib Med Chem. 2015 Jun;30(3):366-70. (PMID: 25032746)
Future Med Chem. 2018 Mar 1;10(5):561-573. (PMID: 29478330)
Nat Rev Drug Discov. 2011 Sep 16;10(10):767-77. (PMID: 21921921)
Expert Opin Ther Pat. 2018 Oct;28(10):713-721. (PMID: 30175635)
J Enzyme Inhib Med Chem. 2019 Dec;34(1):1051-1061. (PMID: 31074307)
Bioorg Med Chem Lett. 2008 Jul 1;18(13):3787-9. (PMID: 18524583)
J Enzyme Inhib Med Chem. 2018 Dec;33(1):151-157. (PMID: 29199489)
Chem Commun (Camb). 2015;51(2):302-5. (PMID: 25407638)
Expert Opin Ther Pat. 2018 Oct;28(10):745-754. (PMID: 29973089)
Curr Pharm Des. 2008;14(7):603-14. (PMID: 18336305)
Metabolites. 2018 Mar 21;8(2):. (PMID: 29561812)
Expert Opin Drug Discov. 2020 Jun;15(6):671-686. (PMID: 32208982)
J Biol Chem. 1971 Apr 25;246(8):2561-73. (PMID: 4994926)
J Enzyme Inhib Med Chem. 2017 Dec;32(1):767-775. (PMID: 28537099)
Chem Biol Drug Des. 2013 Oct;82(4):361-6. (PMID: 23497252)
J Enzyme Inhib Med Chem. 2016 Dec;31(6):1221-5. (PMID: 26598927)
J Enzyme Inhib Med Chem. 2019 Dec;34(1):343-349. (PMID: 30734592)
Expert Opin Investig Drugs. 2018 Dec;27(12):963-970. (PMID: 30426805)
Expert Opin Drug Discov. 2017 Jan;12(1):61-88. (PMID: 27783541)
J Enzyme Inhib Med Chem. 2015;30(4):586-91. (PMID: 25373500)
Mini Rev Med Chem. 2018;18(10):828-836. (PMID: 28971767)
Expert Opin Ther Pat. 2019 Oct;29(10):745-747. (PMID: 31566015)
J Enzyme Inhib Med Chem. 2016;31(3):345-60. (PMID: 26619898)
Bioorg Chem. 2020 Jan;94:103406. (PMID: 31718889)
Eur J Med Chem. 2000 Mar;35(3):309-21. (PMID: 10785557)
Contributed Indexing:
Keywords: Dipeptide; antioxidant; carbonic anhydrase; dihydroquinolinone derivatives
Substance Nomenclature:
0 (Antioxidants)
0 (Biphenyl Compounds)
0 (Carbonic Anhydrase Inhibitors)
0 (Dipeptides)
0 (Isoenzymes)
0 (Picrates)
0 (Quinolones)
0 (dihydroquinolin-2(1H)-one)
DFD3H4VGDH (1,1-diphenyl-2-picrylhydrazyl)
EC 4.2.1.1 (Carbonic Anhydrases)
Entry Date(s):
Date Created: 20200417 Date Completed: 20201221 Latest Revision: 20210507
Update Code:
20240104
PubMed Central ID:
PMC7178833
DOI:
10.1080/14756366.2020.1751620
PMID:
32297533
Czasopismo naukowe
New dipeptide-dihydroquinolinone derivatives were successfully synthesised by benzotriazole mediated nucleophilic acyl substitution reaction and their structures were elucidated by spectroscopic and analytic techniques. The carbonic anhydrase (CA, EC 4.2.1.1) inhibitory activity of the new compounds was determined against four human (h) isoforms, hCA I, hCA II, hCA IX and hCA XII. While all compounds showed moderate to good in vitro CA inhibitory properties against hCA IX and hCA XII with inhibition constants in the micromolar level (37.7-86.8 and 2.0-8.6 µM, respectively), they did not show inhibitory activity against hCA I and hCA II up to 100 µM concentration. The antioxidant capacity of the peptide-dihydroquinolinone conjugates was determined using 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging method. Most of the synthesised compounds showed low antioxidant activities compared to the control antioxidant compounds BHA and α-tocopherol.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies